Lilly will hope that Foundayo continues to dominate and grow over Novo Nordisk in the obesity drug market. Credit: Michael Vi / Shutterstock.com. The US Food and Drug Administration (FDA) has approved Eli Lilly’s orforglipron pill for weight loss, ending Novo Nordisk’s first mover profits in the US after just three months. Oral glucagon-like peptide-1 … Read more
Item 1 of 2 The Zepbound injection pen, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. REUTERS/Brendan McDermid/ File Photo [1/2]Zepbound syringes, Eli Lilly’s weight loss drug, are displayed in New York City, U.S., December 11, 2023. REUTERS/Brendan McDermid/ File Photo Purchase Licensing RIGHTSopen a new tab April … Read more
Item 1 of 2 An injection pen of Novo Nordisk’s weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, November 21, 2023. REUTERS/Victoria Klesty/Illustration/File Photo [1/2]An injection pen from Novo Nordisk’s weight loss drug Wegovy is shown in this photo illustration in Oslo, Norway, November 21, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Purchase Licensing … Read more